Tnf-binding protein-1 in the treatment of psoriasis

Details Tnf-binding protein-1 in the treatment of psoriasis Tnf-binding protein-1 in the treatment of psoriasis

A - Human Necessities

61

K

A61K 38/19 (2006.01)

Patent

CA 2577883

The treatment of psoriasis by administering an anti-TNF-alpha agent is here described. Such a treatment is performed according to specific doses, regimens and route of administration. In particular the anti-TNF-alpha agent is recombinant human TNF-binding protein-1 (r-hTBP-1) and the psoriasis is defined as moderate to severe or associated with psoriatic arthritis.

Il est décrit ici le traitement du psoriasis en administrant un agent anti-TNF-alpha. On effectue un tel traitement selon des dosages, régimes et voie d'administration précis. En particulier l'agent anti-TNF-alpha est une protéine de liaison au TNF de type 1 humaine recombinée (r-hTBP-1) et le psoriasis est défini comme étant modéré à grave ou associé au rhumatisme psoriasique.

Affiliated with

Also associated with

Rating

Tnf-binding protein-1 in the treatment of psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tnf-binding protein-1 in the treatment of psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tnf-binding protein-1 in the treatment of psoriasis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1571356